Is single dose Ebola vaccine durable for 1 to 2 years?

Phase 1 rVSV-ZEBOV trials: antibody persistence assessed at 1 and 2 years in African and European volunteers
Phase 1 rVSV-ZEBOV trials: antibody persistence assessed at 1 and 2 years in African and European volunteers